News
WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."
11 Apr 24
Biotech, News, Global, General
Tonix Pharmaceuticals Q4 EPS $(0.86) Beats $(1.55) Estimate, Sales $3.80M Miss $5.75M Estimate
1 Apr 24
Earnings, Earnings Beats, Earnings Misses, News
Tonix Pharmaceuticals Stock (TNXP) Hits A New All-Time Low: What's Going On?
1 Apr 24
News
12 Health Care Stocks Moving In Friday's Intraday Session
29 Mar 24
Movers
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
28 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated
28 Mar 24
News
12 Health Care Stocks Moving In Thursday's Intraday Session
28 Mar 24
Movers
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation From The FDA For TNX-2900 For The Treatment Of Prader-Willi Syndrome
25 Mar 24
Biotech, News, FDA, General
Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery Of Novel Next-Generation Oxytocin Analogues At The American Chemistry Society Spring 2024 Meeting
21 Mar 24
Biotech, News, General
Tonix Pharmaceuticals Announces Publication In Psychiatry Research Showing Activity Of Bedtime TNX-102 SL On PTSD Symptoms And Sleep Quality In Military-Related PTSD At Four Weeks of Therapy
7 Mar 24
Biotech, News, General
Tonix Pharmaceuticals Announces Translation Of Preclinical Pharmacokinetic Parameters Of TNX-1500 Supports Monthly i.v. Dosing In Humans
5 Mar 24
Biotech, News, General
Dawson James Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $3
28 Feb 24
News, Price Target, Initiation, Analyst Ratings
Tonix Pharmaceuticals Completes Clinical Stage Of Phase 1 Trial For TNX-1500 In Healthy Volunteers
28 Feb 24
Biotech, News, General
Tonix Pharmaceuticals Announces Results From Clinical Pharmacokinetic Bridging Study Of Tonmya To Support Development And Partnering in Japan and China
27 Feb 24
Biotech, News, General
Tonix Pharmaceuticals Announces New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
26 Feb 24
Biotech, News, General
Tonix Pharmaceuticals Hosted KOL Webinar On Phase 3 Fibromyalgia Trial For Tonmya, Plans To File NDA For FDA Approval In Second Half Of 2024
14 Feb 24
Biotech, News, General
Tonix Pharmaceuticals Announces Engagement Of Rho As CRO To Support Submission Of New Drug Application To The FDA For Approval Of Tonmya For The Management Of Fibromyalgia
13 Feb 24
Biotech, News, FDA, General
The FDA Has Cleared Tonix Pharmaceuticals' Investigational New Drug Application For Phase 2 OASIS Trial For TNX-102 SL1 In Reducing The Severity Of Acute Stress Reaction And The Frequency Of Acute Stress Disorder And Posttraumatic Stress Disorder
12 Feb 24
Biotech, News, Health Care, FDA, General
Tonix Pharmaceuticals Research Indicates Pre-Existing Fibromyalgia-Type Symptoms May Increase The Risk Of Developing Long COVID
31 Jan 24
News
Tonix Pharmaceuticals Announces Research Indicating Pre-existing Fibromyalgia-type Symptoms May Increase The Risk Of Developing Long COVID
31 Jan 24
Biotech, News, Health Care, General
Press releases
Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase
24 Apr 24
News, Health Care, Press Releases
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
1 Apr 24
Earnings, Press Releases
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
28 Mar 24
Press Releases
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
25 Mar 24
Health Care, Press Releases
New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV
29 Feb 24
News, Press Releases
Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial
28 Feb 24
Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation
28 Feb 24
New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain
26 Feb 24
News, Press Releases
New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series
23 Feb 24
News, Press Releases, General
New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT
16 Feb 24
News, Press Releases, General
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
15 Feb 24
Press Releases
Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction
15 Feb 24
News, Press Releases
Tonix Pharmaceuticals Pioneering in the shifting landscape of the Dynamic CNS Therapeutics Market
13 Feb 24
New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval
1 Feb 24
News, Press Releases
Tonix Pharmaceuticals Announces Research Indicating Pre-Existing Fibromyalgia-Type Symptoms May Increase the Risk of Developing Long COVID
31 Jan 24
Health Care, Press Releases